Assessment of Exercise Intolerance and Evaluation for HFpEF: A Literature Review of Pathophysiology, Diagnosis, and Management
Pathophysiology · 20.08.2026 · 33 (3) · 63
DOI: 10.3390/pathophysiology33030063 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathophysiology, online erschienen am 20.08.2026. Verfasst von Ali Moradi und 9 weiteren Autor:innen. Beteiligte Einrichtung: HCA Florida Blake Hospital, University of South Florida (USF) Morsani College of Medicine, Bradenton, FL 34209, USA. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Heart failure with preserved ejection fraction (HFpEF) is a type of heart failure in which the ejection fraction remains within the normal range (≥50%); however, patients still experience typical symptoms of heart failure. One of the most common manifestations in this population is exercise intolerance, which in some cases may be the only presenting symptom. Exercise intolerance refers to a reduced capacity to perform physical activity. Several processes, including impaired cGMP–PKG signaling, increased collagen deposition, endothelial dysfunction, increased arterial stiffness, pulmonary hypertension, and vascular remodeling, contribute to the pathophysiology of HFpEF. The disruption of these fundamental physiological processes significantly impairs exercise capacity, leading to attenuated increases in heart rate, stroke volume, and/or contractility, along with abnormal ventricular–vascular coupling during exertion. When EI is suspected, a spectrum of diagnostic modalities—from simple, low-cost tools such as the 6 min walk test to advanced imaging—can be used to evaluate its presence and its association with HFpEF. When EI in HFpEF is diagnosed, management should focus on addressing this limitation to improve quality of life and reduce morbidity and mortality. Exercise training and pharmacological therapies, such as SGLT2 inhibitors, may be beneficial in this population. In conclusion, EI is a common manifestation of HFpEF that significantly impacts patients’ quality of life. Understanding its underlying mechanisms and addressing it appropriately are essential to improving patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- HCA Florida Blake Hospital, University of South Florida (USF) Morsani College of Medicine, Bradenton, FL 34209, USA.
- Department of Medicine, USF Health Morsani College of Medicine, Tampa, FL 33602, USA.
ORCID-Profile: Abdullah Sahyouni, Shivanshu Kumar, Elaine Pan, Grant Barton, Olugbenga Oyesanmi
Zitieren
APA
Moradi, A., Ramey, K., Tabbaa, K., Sahyouni, A., Sanchez Garcez, K., Kumar, S., Pan, E., Barton, G., Oyesanmi, O., & Subbiondo, R. (2026). Assessment of Exercise Intolerance and Evaluation for HFpEF: A Literature Review of Pathophysiology, Diagnosis, and Management. Pathophysiology, 33(3), 63. https://doi.org/10.3390/pathophysiology33030063
Vancouver
Moradi A, Ramey K, Tabbaa K, Sahyouni A, Sanchez Garcez K, Kumar S, et al. Assessment of Exercise Intolerance and Evaluation for HFpEF: A Literature Review of Pathophysiology, Diagnosis, and Management. Pathophysiology. 2026;33(3):63. doi:10.3390/pathophysiology33030063
BibTeX
@article{Moradi2026,
author = {Moradi, Ali and Ramey, Kurt and Tabbaa, Kutiba and Sahyouni, Abdullah and Sanchez Garcez, Kevin and Kumar, Shivanshu and Pan, Elaine and Barton, Grant and Oyesanmi, Olugbenga and Subbiondo, Robert},
title = {Assessment of Exercise Intolerance and Evaluation for HFpEF: A Literature Review of Pathophysiology, Diagnosis, and Management},
journal = {Pathophysiology},
year = {2026},
volume = {33},
number = {3},
pages = {63},
doi = {10.3390/pathophysiology33030063}
}
EUVIMED